MassDevice.com +5 | The top 5 medtech stories for May 17, 2016

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Biostage unveils $5 million offering for organ regeneration tech Organ regeneration specialist Biostage, formerly know as Harvard Apparatus Regenerative Technology, announced that it will offer $5 million worth of common stock May 19 to fund its ongoing R&D efforts. BSTG shares closed down -3.5% at $1.65 apiece yesterday on the news. Read more 4. Staar Surgical wins Health Canada nod as shares hit 52-week low Implantable contact lens maker Staar Surgical said it earned Health Canada approval to sell its EVO Visian ICL in the country. The device to correct myopia and astigmatism is permanently implanted between the iris and the eye’s natural lens. Staar sells 3 implantable lenses under its Visian franchise, but none are available in the U.S., according to the company’s website. Read more 3. BioVentrix touts 1st-in-human procedure for Revivent device BioVentrix said it successfully implanted its micro-anchor Revivent device into a 64-year-old female patient suffering from heart failure symptoms following a heart attack. The first-in-human test follows a simil...
Source: Mass Device - Category: Medical Equipment Authors: Tags: News Well Plus 5 Source Type: news